To Look Beyond Vasospasm in Aneurysmal Subarachnoid Haemorrhage

被引:51
作者
Cossu, Giulia [1 ]
Messerer, Mahmoud [1 ]
Oddo, Mauro [2 ]
Daniel, Roy Thomas [1 ]
机构
[1] Univ Lausanne, Fac Human Med & Biol, Dept Neurosurg, CHU Vaudois, CH-1011 Lausanne, Switzerland
[2] Univ Lausanne, Fac Human Med & Biol, Dept Intens Care Med, CHU Vaudois, CH-1011 Lausanne, Switzerland
关键词
CEREBRAL-BLOOD-FLOW; EARLY BRAIN-INJURY; ENDOTHELIN RECEPTOR ANTAGONIST; MICROVASCULAR BASAL LAMINA; NITRIC-OXIDE SYNTHASE; DOUBLE-BLIND; SPREADING DEPOLARIZATION; CEREBROSPINAL-FLUID; PERIINFARCT DEPOLARIZATIONS; INFLAMMATORY RESPONSE;
D O I
10.1155/2014/628597
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
Delayed cerebral vasospasm has classically been considered the most important and treatable cause of mortality and morbidity in patients with aneurysmal subarachnoid hemorrhage (aSAH). Secondary ischemia (or delayed ischemic neurological deficit, DIND) has been shown to be the leading determinant of poor clinical outcome in patients with aSAH surviving the early phase and cerebral vasospasm has been attributed to being primarily responsible. Recently, various clinical trials aimed at treating vasospasm have produced disappointing results. DIND seems to have a multifactorial etiology and vasospasm may simply represent one contributing factor and not the major determinant. Increasing evidence shows that a series of early secondary cerebral insults may occur following aneurysm rupture (the so-called early brain injury). This further aggravates the initial insult and actually determines the functional outcome. A better understanding of these mechanisms and their prevention in the very early phase is needed to improve the prognosis. The aim of this review is to summarize the existing literature on this topic and so to illustrate how the presence of cerebral vasospasm may not necessarily be a prerequisite for DIND development. The various factors determining DIND that worsen functional outcome and prognosis are then discussed.
引用
收藏
页数:14
相关论文
共 158 条
[11]   Rebleeding, secondary ischemia, and timing of operation in patients with subarachnoid hemorrhage [J].
Brilstra, EH ;
Rinkel, GJE ;
Algra, A ;
van Gijn, J .
NEUROLOGY, 2000, 55 (11) :1656-1660
[12]   Apoptotic Mechanisms After Cerebral Ischemia [J].
Broughton, Brad R. S. ;
Reutens, David C. ;
Sobey, Christopher G. .
STROKE, 2009, 40 (05) :E331-E339
[13]   Factors affecting excitatory amino acid release following severe human head injury [J].
Bullock, R ;
Zauner, A ;
Woodward, JJ ;
Myseros, J ;
Choi, SC ;
Ward, JD ;
Marmarou, A ;
Young, HF .
JOURNAL OF NEUROSURGERY, 1998, 89 (04) :507-518
[14]   Vasospasm and p53-induced apoptosis in an experimental model of subarachnoid hemorrhage [J].
Cahill, Julian ;
Calvert, John W. ;
Solaroglu, Ihsan ;
Zhang, John H. .
STROKE, 2006, 37 (07) :1868-1874
[15]   Mechanisms of early brain injury after subarachnoid hemorrhage [J].
Cahill, W. Julian ;
Calvert, John H. ;
Zhang, John H. .
JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM, 2006, 26 (11) :1341-1353
[16]   Reactive oxygen radicals in signaling and damage in the ischemic brain [J].
Chan, PH .
JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM, 2001, 21 (01) :2-14
[17]   Differential effects of amrinone and milrinone upon myocardial inflammatory signaling [J].
Chanani, NK ;
Cowan, DB ;
Takeuchi, K ;
Poutias, DN ;
Garcia, LM ;
del Nido, PJ ;
McGowan, FX .
CIRCULATION, 2002, 106 (13) :I284-I289
[18]   Bilirubin oxidation products (BOXes) and their role in cerebral vasospasm after subarachnoid hemorrhage [J].
Clark, Joseph F. ;
Sharp, Frank R. .
JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM, 2006, 26 (10) :1223-1233
[19]   Angiographic Vasospasm Is Strongly Correlated With Cerebral Infarction After Subarachnoid Hemorrhage [J].
Crowley, R. Webster ;
Medel, R. ;
Dumont, Aaron S. ;
Ilodigwe, Don ;
Kassell, Neal F. ;
Mayer, Stephan A. ;
Ruefenacht, Daniel ;
Schmiedek, Peter ;
Weidauer, Stephan ;
Pasqualin, Alberto ;
Macdonald, R. Loch .
STROKE, 2011, 42 (04) :919-923
[20]   SERUM NEURON-SPECIFIC ENOLASE CONCENTRATIONS IN PATIENTS WITH NEUROLOGICAL DISORDERS [J].
CUNNINGHAM, RT ;
MORROW, JI ;
JOHNSTON, CF ;
BUCHANAN, KD .
CLINICA CHIMICA ACTA, 1994, 230 (02) :117-124